N
Nicole Mittmann
Researcher at Sunnybrook Health Sciences Centre
Publications - 242
Citations - 5421
Nicole Mittmann is an academic researcher from Sunnybrook Health Sciences Centre. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 37, co-authored 216 publications receiving 4702 citations. Previous affiliations of Nicole Mittmann include Sunnybrook Research Institute & Cancer Care Ontario.
Papers
More filters
Journal ArticleDOI
Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people
Barbara Liu,Geoff Anderson,Nicole Mittmann,Teresa To,Tami Axcell,Neil H. Shear,Neil H. Shear +6 more
TL;DR: Exposure to any of the three classes of antidepressants is associated with a significant increase in the risk of hip fracture, and despite differences in dose distribution, this analysis suggests that SSRIs do not offer an advantage over TCAs in terms of risk of Hip fracture.
Journal ArticleDOI
Utility scores for chronic conditions in a community-dwelling population.
TL;DR: This study provides health economists, researchers and policymakers with a reference for health utilities of various chronic conditions, different age groups, gender and comorbidities.
Journal ArticleDOI
A validation study of The Geriatric Depression Scale short form
Nathan Herrmann,Nicole Mittmann,Ivan Silver,Kenneth I. Shulman,Usoa Busto,Neil H. Shear,Claudio A. Naranjo +6 more
TL;DR: The Geriatric Depression Scale short form appears to be a useful, valid screening instrument in this population of geriatric affective disorders patients.
Journal ArticleDOI
The cost of moderate and severe COPD exacerbations to the Canadian healthcare system.
Nicole Mittmann,Nicole Mittmann,Lisa Kuramoto,S.J. Seung,Jennifer M Haddon,Carole Bradley-Kennedy,J.M. FitzGerald +6 more
TL;DR: The economic burden associated with MEs and especially SEs, in Canada, is considerable and likely has a substantial impact on healthcare costs.
Journal ArticleDOI
Efficacy and safety of neuroleptics in behavioral disorders associated with dementia.
Krista L. Lanctôt,Tamara S. Best,Nicole Mittmann,Barbara A. Liu,Paul Oh,Thomas R. Einarson,Claudio A. Naranjo +6 more
TL;DR: Neuroleptics have small but significant efficacy over placebo in this population of dementia patients, and the efficacy rate is equivalent to the side effect rate.